19Aug/13

Heart's Own Stem Cells Can Be Used To Treat Heart Failure: Study – Headlines & Global News


Headlines & Global News

Heart’s Own Stem Cells Can Be Used To Treat Heart Failure: Study
Headlines & Global News
Heart Failure is the cause of 287,000 deaths a year with over 5 million Americans currently living with some form of heart diseases. Approximately, 550,000 new cases are diagnosed in the U.S. each year with this disease being the leading cause of death
Heart’s own stem cells could help treat cardiac failureIndia.Com Health

all 2 news articles »

19Aug/13

German organ donor scandal doctor goes on trial – BBC News


BBC News

German organ donor scandal doctor goes on trial
BBC News
A doctor accused of falsifying patients’ information to push them up an organ transplant list goes on trial in Germany on Monday. It is alleged the doctor falsified information in at least 25 cases, and accepted money from multiple patients outside
Donor scandal doctor blasts ‘absurd’ chargesThe Local.de
Organ transplant fraud trial opens in GermanyDeutsche Welle

all 5 news articles »

19Aug/13

Children's Cancer Recovery Foundation Reveals New Antibodies that May Fight … – DigitalJournal.com

Children’s Cancer Recovery Foundation Reveals New Antibodies that May Fight
DigitalJournal.com
The article explains that they “have developed two monoclonal antibodies called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4.” The antibodies bind to different molecules in the immune system and stimulate its response in

and more »

19Aug/13

Children's Cancer Recovery Foundation Reveals New Antibodies that May Fight … – EIN News (press release)

Children’s Cancer Recovery Foundation Reveals New Antibodies that May Fight
EIN News (press release)
The article explains that they “have developed two monoclonal antibodies called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4.” The antibodies bind to different molecules in the immune system and stimulate its response in

and more »

19Aug/13

Market Access Granted in France for Aggressive non-Hodgkin Lymphoma … – The Herald | HeraldOnline.com

Market Access Granted in France for Aggressive non-Hodgkin Lymphoma
The Herald | HeraldOnline.com
The European Medicines Agency’s (the EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled Phase 3 clinical trial, which compares PIXUVRI-rituximab to gemcitabine-rituximab in patients who 
CELL THERAPEUTICS INC : Market Access Granted in France for Aggressive 4-traders (press release)

all 7 news articles »